AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 90c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of ($0.72), $0.90 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $43.11 million versus the consensus estimate of $8.44 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Underweight
• The Trade Desk (TTD) Reiterated at Market Perform by Citizens Amid Bad News